The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1133705410 11337054 10 F 20150618 20160809 20150804 20160816 EXP IE-ALEXION PHARMACEUTICALS INC-A201502474 ALEXION 53.29 YR F Y 0.00000 20160816 PH IE IE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1133705410 11337054 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W P0002902 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
1133705410 11337054 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W POOO3202 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
1133705410 11337054 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W P0003302 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
1133705410 11337054 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W P0004707 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
1133705410 11337054 5 C DIPROSALIC BETAMETHASONE DIPROPIONATE 1 Topical 0 CREAM
1133705410 11337054 6 C VALTREX VALACYCLOVIR HYDROCHLORIDE 1 Unknown 0
1133705410 11337054 7 C DUODERM /00504601/ 2 Unknown 0
1133705410 11337054 8 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Unknown 0
1133705410 11337054 9 C GAVISCON /00237601/ ALUMINUM HYDROXIDEMAGNESIUM CARBONATE 1 Unknown 0
1133705410 11337054 10 C ZOTON LANSOPRAZOLE 1 Unknown 30 MG, QD 0 30 MG QD
1133705410 11337054 11 C CALVEPEN 2 Other 666 MG, BID 0 666 MG BID
1133705410 11337054 12 C FOLIC ACID. FOLIC ACID 1 Other 5 MG, QD 0 5 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1133705410 11337054 1 Paroxysmal nocturnal haemoglobinuria
1133705410 11337054 5 Product used for unknown indication
1133705410 11337054 6 Product used for unknown indication
1133705410 11337054 7 Product used for unknown indication
1133705410 11337054 8 Product used for unknown indication
1133705410 11337054 9 Product used for unknown indication
1133705410 11337054 10 Product used for unknown indication
1133705410 11337054 11 Product used for unknown indication
1133705410 11337054 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1133705410 11337054 OT
1133705410 11337054 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1133705410 11337054 Drug ineffective
1133705410 11337054 Haemoglobin decreased
1133705410 11337054 Low density lipoprotein abnormal
1133705410 11337054 Myelodysplastic syndrome
1133705410 11337054 Neutrophil count decreased
1133705410 11337054 Platelet count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1133705410 11337054 1 20111125 0
1133705410 11337054 2 20111125 0
1133705410 11337054 3 20111125 0
1133705410 11337054 4 20111125 0